CN101450187A - Medicine composition for treating asthma - Google Patents

Medicine composition for treating asthma Download PDF

Info

Publication number
CN101450187A
CN101450187A CNA2007101161068A CN200710116106A CN101450187A CN 101450187 A CN101450187 A CN 101450187A CN A2007101161068 A CNA2007101161068 A CN A2007101161068A CN 200710116106 A CN200710116106 A CN 200710116106A CN 101450187 A CN101450187 A CN 101450187A
Authority
CN
China
Prior art keywords
grams
asthma
treatment
ramulus
cortex moutan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101161068A
Other languages
Chinese (zh)
Inventor
李勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2007101161068A priority Critical patent/CN101450187A/en
Publication of CN101450187A publication Critical patent/CN101450187A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the Chinese medicine field, in particularly a medicinal composition which is prepared from Chinese medicinal materials including 10-30g biota orientalis, 11-16g boxwood, 13-18g heartleaf houtluynia, 6-12g shanzhuying, 10-30g artemisia leaf, 4-10g yellow seedling, 3-15g schisandra, 2-10g balloonflower, 3-6g bulbus fritilariae, 5-10g dioscorea opposita, 2-5g ephedra, 5-9g cassia twig, 5-15g glycyrrhiza, 3-12g tangerine peel, 2-15g rhizoma pinellinae praeparata, 4-20g cortex moutan, 2-25g honey. The medicinal composition has advantages of better curative effect, short curative period and little side effect.

Description

A kind of pharmaceutical composition for the treatment of asthma
Technical field:
The present invention relates to the Chinese medicine preparation field, especially a kind of pharmaceutical composition for the treatment of asthma.
Background technology:
Along with economical flourish in recent years, brought many negative influences also for people's life, for example environmental pollution etc. along with, thereby caused the rising of the sickness rate of human asthma, serious harm people healthy.For the various asthmas of human body, in prevention and treatment, still there is not ideal medicine both at home and abroad at present, though there are some medicines can manifest certain curative effect, but treatment time is long, and side effect is big, can't reach ideal effect, can only the respite symptom, be difficult to fundamentally disease thoroughly be cured.
Summary of the invention:
The invention provides a kind of pharmaceutical composition for the treatment of asthma, its therapeutic effect is good, and treatment time is short, and side effect is little, has solved problems of the prior art.
The present invention solves the problems of the technologies described above the technical scheme that is adopted to be: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 10~30 grams by the following raw materials in weight medicine; Ramulus Buxi Sinicae 11~16 grams; Herba Houttuyniae 13~18 grams; Mountain Zhu English 6~12 grams; Folium Artemisiae Argyi 10~30 grams; HUANGMIAO 4~10 grams, Fructus Schisandrae Chinensis 3~15 grams; Radix Platycodonis 2~10 grams; Bulbus Fritillariae Cirrhosae 3~6 grams; Rhizomadioscoreae 5~10 grams; Herba Ephedrae 2~5 grams; Ramulus Cinnamomi 5~9 grams; Radix Glycyrrhizae 5~15 grams; Pericarpium Citri Reticulatae 3~12 grams; Rhizoma Pinelliae Preparata 2~15 grams; Cortex Moutan 4~20 grams; Mel 2~25 grams.
The concrete consumption of above-mentioned each crude drug is: Cacumen Platycladi 15 grams; Ramulus Buxi Sinicae 13 grams; Herba Houttuyniae 15 grams; Mountain Zhu English 8 grams; Folium Artemisiae Argyi 15 grams; HUANGMIAO 6 grams, Fructus Schisandrae Chinensis 10 grams; Radix Platycodonis 7 grams; Bulbus Fritillariae Cirrhosae 4 grams; Rhizomadioscoreae 6 grams; Herba Ephedrae 3 grams; Ramulus Cinnamomi 6 grams; Radix Glycyrrhizae 12 grams; Pericarpium Citri Reticulatae 6 grams; Rhizoma Pinelliae Preparata 9 grams; Cortex Moutan 16 grams; Mel 18 grams.
The present invention has adopted numerous traditional treatment asthma Chinese herbal medicine compositions, and Cacumen Platycladi, Folium Artemisiae Argyi one a cold atmosphere is crossed slow profit each other and got, and is mutually proper clear, fill in puckery can rush down make under, Wen Xinneng is eliminating evil to go out key.Herba Houttuyniae and Ramulus Buxi Sinicae have the specially good effect of antiinflammatory, heat-clearing and toxic substances removing, expelling wind and removing dampness, and can improve blood circulation, the enhancing body immunity of human body.Mel is transferred to moisten the QI invigorating invigorating middle warmer, and it is capable to reach dirty peace internal organs.The curative effects such as bronchial asthma, asthmatic bronchitis, intractable cough of body being considered weak person and outbreak repeatedly are excellent.By the clinical trial certificate of 160 many cases asthma patients, this medicine is after treating three courses of treatment, and the overwhelming majority can recover normal, its cure rate reaches about 92%, and its effective percentage reaches more than 98%, and side effect is little, and expectorant, cough, breathe heavily, inflammation and General Symptoms improve, the getting rid of illness of asthmatic patient clothes.
The specific embodiment:
For clearly demonstrating the technical characterstic of this programme, below by the specific embodiment, the present invention will be described in detail.
Embodiment 1: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 15 grams by the following raw materials in weight medicine; Ramulus Buxi Sinicae 13 grams; Herba Houttuyniae 15 grams; Mountain Zhu English 8 grams; Folium Artemisiae Argyi 15 grams; HUANGMIAO 6 grams, Fructus Schisandrae Chinensis 10 grams; Radix Platycodonis 7 grams; Bulbus Fritillariae Cirrhosae 4 grams; Rhizomadioscoreae 6 grams; Herba Ephedrae 3 grams; Ramulus Cinnamomi 6 grams; Radix Glycyrrhizae 12 grams; Pericarpium Citri Reticulatae 6 grams; Rhizoma Pinelliae Preparata 9 grams; Cortex Moutan 16 grams; Mel 18 grams.
Embodiment 2: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 10 grams by the following raw materials in weight medicine; Ramulus Buxi Sinicae 11 grams; Herba Houttuyniae 13 grams; Mountain Zhu English 6 grams; Folium Artemisiae Argyi 10 grams; HUANGMIAO 4 grams, Fructus Schisandrae Chinensis 3 grams; Radix Platycodonis 2 grams; Bulbus Fritillariae Cirrhosae 3 grams; Rhizomadioscoreae 5 grams; Herba Ephedrae 2 grams; Ramulus Cinnamomi 5 grams; Radix Glycyrrhizae 5 grams; Pericarpium Citri Reticulatae 3 grams; Rhizoma Pinelliae Preparata 2 grams; Cortex Moutan 4 grams; Mel 2 grams.
Embodiment 3: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 30 grams by the following raw materials in weight medicine; Ramulus Buxi Sinicae 16 grams; Herba Houttuyniae 18 grams; Mountain Zhu English 12 grams; Folium Artemisiae Argyi 30 grams; HUANGMIAO 10 grams, Fructus Schisandrae Chinensis 15 grams; Radix Platycodonis 10 grams; Bulbus Fritillariae Cirrhosae 6 grams; Rhizomadioscoreae 10 grams; Herba Ephedrae 5 grams; Ramulus Cinnamomi 9 grams; Radix Glycyrrhizae 15 grams; Pericarpium Citri Reticulatae 12 grams; Rhizoma Pinelliae Preparata 15 grams; Cortex Moutan 20 grams; Mel 25 grams.
Embodiment 4: a kind of pharmaceutical composition for the treatment of asthma, mainly make: Cacumen Platycladi 10 grams by the following raw materials in weight medicine; Ramulus Buxi Sinicae 11 grams; Herba Houttuyniae 13 grams; Mountain Zhu English 6 grams; Folium Artemisiae Argyi 25 grams; HUANGMIAO 8 grams, Fructus Schisandrae Chinensis 15 grams; Radix Platycodonis 10 grams; Bulbus Fritillariae Cirrhosae 6 grams; Rhizomadioscoreae 10 grams; Herba Ephedrae 2 grams; Ramulus Cinnamomi 7 grams; Radix Glycyrrhizae 10 grams; Pericarpium Citri Reticulatae 9 grams; Rhizoma Pinelliae Preparata 12 grams; Cortex Moutan 15 grams; Mel 20 grams.

Claims (2)

1, a kind of pharmaceutical composition for the treatment of asthma is characterized in that: mainly made by the following raw materials in weight medicine: Cacumen Platycladi 10~30 grams; Ramulus Buxi Sinicae 11~16 grams; Herba Houttuyniae 13~18 grams; Mountain Zhu English 6~12 grams; Folium Artemisiae Argyi 10~30 grams; HUANGMIAO 4~10 grams, Fructus Schisandrae Chinensis 3~15 grams; Radix Platycodonis 2~10 grams; Bulbus Fritillariae Cirrhosae 3~6 grams; Rhizomadioscoreae 5~10 grams; Herba Ephedrae 2~5 grams; Ramulus Cinnamomi 5~9 grams; Radix Glycyrrhizae 5~15 grams; Pericarpium Citri Reticulatae 3~12 grams; Rhizoma Pinelliae Preparata 2~15 grams; Cortex Moutan 4~20 grams; Mel 2~25 grams.
2, a kind of pharmaceutical composition for the treatment of asthma according to claim 1, it is characterized in that: the concrete consumption of above-mentioned each crude drug is: Cacumen Platycladi 15 grams; Ramulus Buxi Sinicae 13 grams; Herba Houttuyniae 15 grams; Mountain Zhu English 8 grams; Folium Artemisiae Argyi 15 grams; HUANGMIAO 6 grams, Fructus Schisandrae Chinensis 10 grams; Radix Platycodonis 7 grams; Bulbus Fritillariae Cirrhosae 4 grams; Rhizomadioscoreae 6 grams; Herba Ephedrae 3 grams; Ramulus Cinnamomi 6 grams; Radix Glycyrrhizae 12 grams; Pericarpium Citri Reticulatae 6 grams; Rhizoma Pinelliae Preparata 9 grams; Cortex Moutan 16 grams; Mel 18 grams.
CNA2007101161068A 2007-12-07 2007-12-07 Medicine composition for treating asthma Pending CN101450187A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007101161068A CN101450187A (en) 2007-12-07 2007-12-07 Medicine composition for treating asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007101161068A CN101450187A (en) 2007-12-07 2007-12-07 Medicine composition for treating asthma

Publications (1)

Publication Number Publication Date
CN101450187A true CN101450187A (en) 2009-06-10

Family

ID=40732785

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101161068A Pending CN101450187A (en) 2007-12-07 2007-12-07 Medicine composition for treating asthma

Country Status (1)

Country Link
CN (1) CN101450187A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102335327A (en) * 2011-11-05 2012-02-01 许从玉 Pharmaceutical composition for treating asthma
CN102949577A (en) * 2012-11-16 2013-03-06 桐乡市濮院毛针织技术服务中心 Drug for treating asthma
CN104208489A (en) * 2014-09-23 2014-12-17 河南科技大学第一附属医院 Chinese herbal medicine pill for treating pneumonia and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102335327A (en) * 2011-11-05 2012-02-01 许从玉 Pharmaceutical composition for treating asthma
CN102335327B (en) * 2011-11-05 2013-04-10 许从玉 Pharmaceutical composition for treating asthma
CN102949577A (en) * 2012-11-16 2013-03-06 桐乡市濮院毛针织技术服务中心 Drug for treating asthma
CN104208489A (en) * 2014-09-23 2014-12-17 河南科技大学第一附属医院 Chinese herbal medicine pill for treating pneumonia and preparation method thereof

Similar Documents

Publication Publication Date Title
CN100496586C (en) Medicinal liquor for treating hyperosteogency and koilorrhachic
CN101028507A (en) Chinese-medicinal composition for treating asthma
CN101693089A (en) Traditional Chinese medicine compound for treating diseases of lung Qi obstruction and dyspnea chest discomfort and preparation method thereof
CN1091609C (en) Tincture for treating rheumatoid arthritis and its preparing process
CN101780167A (en) Chinese medicine compound for preventing and curing lung diseases and clearing human body toxin and preparation method thereof
CN100998656A (en) Medicated wine for tonifying bone and removing obstruction in channels
CN1390585A (en) Chinese medicine for detoxication purpose and its preparing process
CN101152372A (en) Traditional Chinese medicine for treating children's urorrhea of liver channel damp-heat
CN101450187A (en) Medicine composition for treating asthma
CN101138613A (en) Chinese traditional medicine for treating acute bronchitis of children
CN101152494A (en) Traditional Chinese medicine for treating acute appendicitis
CN103341063B (en) Chinese medicine composition for treating wind-heat cough
CN103251864A (en) Chinese medicament for treating pneumonia and preparation method thereof
CN101912567A (en) Chinese medicinal prescription for treating chronic myocarditis
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN1879749A (en) Medicinal heath wine
CN103301411A (en) Traditional Chinese medicine wine for treating soft tissue injury and preparation method thereof
CN103385998B (en) Traditional Chinese medicine preparation used for treating infantile dysentery
CN102274334A (en) Medicine for treating rhinitis and preparation method thereof
CN101757412A (en) Medicine composition for treating asthma
CN1069053C (en) Oral medicine for curing phlegm-heat cough
CN100394976C (en) Chinese medicine for withdrawal of drug dependence
CN101143199A (en) Traditional Chinese medicine for treating chronic bronchitis
CN102366591B (en) Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method
CN102228560A (en) Medicine for treating chronic pharyngitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
DD01 Delivery of document by public notice

Addressee: Li Yong

Document name: the First Notification of an Office Action

DD01 Delivery of document by public notice

Addressee: Li Yong

Document name: Notification that Application Deemed to be Withdrawn

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090610